News

  • 08 July 2014
    New frontiers in GI healthcare technology development. Wednesday 8 October 2014 - The Royal Society of Medicine, 1 Wimpole St, London W1G 0AE A one-day event providing a major networking opportunity for clinicians, industry, patients and healthcare...
  • 07 July 2014
    Diabetes treatment in the United States could be due for some radical change now that the FDA has approved MannKind Corp.’s Afrezza fast-acting, inhalable insulin. Valencia, CA–based MannKind announced the approval late last week. Type 1 diabetics...
  • 07 July 2014
    Antibiotic resistance has been selected as the focus for a £10m prize set up to tackle a major challenge of our time. Six themes were initially identified by organisers of the Longitude Prize; these were then put to a public vote.  The winning theme was...
  • 07 July 2014
    Undergraduate bioengineering students at Johns Hopkins University in Maryland have developed a lightweight defibrillator ‘shirt.' The shirt could potentially allow patients at high risk of cardiac arrest or serious arrhythmias to wear a user-friendly,...
  • 07 July 2014
    The row over NHS England's big data programme - care.data - refuses to die down after the British Medical Association waded into the debate by demanding the scheme be explicitly opt-in only when it is rolled out. During the BMA’s annual representative...
  • 07 July 2014
    A lack of access to real-time patient information is affecting the ability of 88% of community health workers to perform their roles, according to a study of 17 healthcare organisations throughout the UK. The research, undertaken by mobile solutions provider,...
  • 07 July 2014
    The Royal College of Surgeons and Age UK looked at surgery rates for six common procedures for English over-65s. It found a wide variation in access to treatment depending on where people lived and a "worrying" difference between the over 65s and over...
  • 07 July 2014
    Researchers believe that we may be one step closer to being able to use 3D-printed tissue in organ transplant surgery. Over the last year or so we've seen a remarkable number of situations in which 3D printing technology has been deployed in the medical world...
  • 03 July 2014
    Giant healthcare conglomerate Johnson & Johnson has announced that it has completed the sale of its Ortho-Clinical Diagnostics (OCD) business to The Carlyle Group for approximately $4 billion. In conjunction with the sale of OCD, Robert Yates will assume the...
  • 03 July 2014
    The National Institute for Health and Care Excellence (NICE) said it will cover Johnson & Johnson subsidiary Janssen-Cilag’s diabetes drug Invokana (canagliflozin) as a treatment for people with type 2 Diabetes. The decision, which will allow the drug to...
RSS feed

https://www.medilinkuk.com/sites/default/files/uploads/UK-LifeScience-Industry-Magazine-advert_7.jpg